AI-generated analysis. Always verify with the original filing.
Challenging year marked by deepening operating losses and a 26% revenue decline as the company struggled to commercialize its telemedicine platform, offset only by aggressive equity financing that provided temporary liquidity but diluted shareholders significantly.
EPS
$-2.17
Revenue
$456.0K
Net Income
-$20.6M
Gross Margin
54.9%
Gross Profit
$250.4K
Operating Income
-$18.0M
operating margin
-3954.3%